Media
Read our latest media releases, news and stories to find out what we’re doing and where.
Did you know that Centrient Americas is the only major Penicillin G producer outside China?
read more
Did you know that Centrient Pharmaceuticals is a global market leader in Nystatin, supplying to all major markets?
read more
Did you know that Centrient Pharmaceuticals is one of the largest and most sustainable commercial statin API producers worldwide?
read moreCentrient Pharmaceuticals boosting statins API manufacturing capacity
Centrient Pharmaceuticals (“Centrient”), the global leader in sustainable antibiotics, next-generation statins and anti-fungals, announced today to have started production at its new statins manufacturing unit. With the building of its second dedicated unit on the Toansa site in India now completed, the company will double its statins production capacity. This will enable Centrient to meet growing demand for its sustainably manufactured Atorvastatin and Rosuvastatin Active Pharmaceutical Ingredients (APIs).
read more
Saving lives in COVID-19 times: Mission Oxygen in India
The second wave of COVID-19 has had a significant impact in India and many hospitals could not provide life-saving oxygen to patients in need.
read more
Did you know that every second patient who gets a first-generation Cephalosporin antibiotic has a product made by Centrient!
read more
Focusing on sustainable shipping and reliable supply
At Centrient Pharmaceuticals, Quality, Reliability, and Sustainability are at the heart of everything we do. It shapes how we do things, from manufacturing and distribution to our partnerships and community engagement.
read more
Did you know that Centrient’s Amoxicillin products contribute to 1 billion patient treatments each year?
read moreCentrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms
Centrient Pharmaceuticals, the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the signing of an agreement for the acquisition of Astral SteriTech Private Limited, a leading international manufacturer specialised in sterile antibiotic injectable finished dosage forms. With the acquisition of Astral SteriTech, Centrient strengthens its position as the global business-to-business industry leader in beta-lactam antibiotics.
read moreCentrient Pharmaceuticals recieves 2020 Gold Sustainability Rating
read more
We SpeakUp in case of misconduct
At Centrient Pharmaceuticals, our aim is always total transparency and integrity. With the help of our new Centrient SpeakUp procedure, in place since November 2020, our employees, business partners and other stakeholders can report any potential concerns regarding (possible) misconduct in the strictest confidence.
read moreOur Sustainability Report 2019
Sustainability matters a great deal to everyone at Centrient Pharmaceuticals, it is core to our mission and essential in shaping our authentic and purposeful culture.
read more
media@centrient.com